Save Time, Money, and Samples through Test Consolidation
• Pan-cancer content aligned with key guidelines
• DNA + RNA* assay targeting 523 genes for assessment of small variants, TMB, MSI, splice variants, and fusions
• Identify relevant alterations while achieving highly accurate results
• Achieve Highly Confident Results
• Software filters artifacts for accurate variant calling
• Enrichment chemistry inclusive of unique molecular indexes (UMIs) for high sensitivity in variant detection
• Based on proven Illumina platform
• Unlock Immuno-Oncology
• Panel contains immuno-oncology biomarkers TMB and MSI
• Tumor-only workflow for simplicity and efficiency
• TMB calling performance similar to whole-exome sequencing (WES) panels
• Large 1.94 Mb panel and sophisticated algorithm for accurate TMB score